Spirovant Sciences is developing novel gene therapies for cystic fibrosis and other pulmonary diseases. We are the only company advancing programs with both AAV and lentivirus vectors.
| Website | http://www.spirovant.com |
| Employees | 16 (12 on RocketReach) |
| Founded | 2016 |
| Address | 3675 Market St Suite 900, Philadelphia, Pennsylvania 19104, US |
| Phone | +1 267-244-8206 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Delivery, Healthcare |
| Keywords | Gene Therapy, Cystic Fibrosis Treatment, Aav Gene Therapy, Respiratory Disease Treatment, Genetic Disease Treatment, Lung Disease Treatment, Respiratory Therapeutics, Cf Treatment, Gene Therapy Development |
| Competitors | AstraZeneca, Gilead Sciences, Vertex Pharmaceuticals, Moderna Therapeutics, BioMarin Pharmaceutical Inc., Incyte, bluebird bio, CureVac, Sutro Biopharma, Inc., Sarepta Therapeutics, Inc. +36 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Spirovant Sciences, Inc. employee's phone or email?
David Whitwell is the CFO of Spirovant Sciences, Inc..
12 people are employed at Spirovant Sciences, Inc..
Spirovant Sciences, Inc. is based in Philadelphia, Pennsylvania.
The NAICS codes for Spirovant Sciences, Inc. are [541, 541714, 5417, 54, 54171].
The SIC codes for Spirovant Sciences, Inc. are [873, 87].